MedPath

Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy

Phase 3
Conditions
Liver Disease
Interventions
Procedure: indocyanine green fluorescent cholangiography
Registration Number
NCT01847612
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

The aim of the present study is to evaluate whether the use of indocyanine green fluorescent cholangiography is responsible in a decrease of biliary fistula's rate in patients with liver diseases requiring liver resection.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
132
Inclusion Criteria
  • benin or malignant liver disease with resection of 2 or more segments
  • liver resection by laparotomy
  • written consent
Exclusion Criteria
  • previous hepatectomy
  • emergency surgery
  • allergy to indocyanine green
  • allergy to methylene blue
  • pregnancy or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
indocyanine green fluorescent cholangiographyindocyanine green fluorescent cholangiographyuse of indocyanine green fluorescent cholangiography in the patients of this arm, an indocyanine green fluorescent cholangiography is performed
methylene bluemethylene blueinjection of methylene blue during the surgery
Primary Outcome Measures
NameTimeMethod
biliary fistula ratepostoperative week 4

the biliary fistula is defined as a bilirubin in the drain three times higher than the serum bilirubin.

the primary endpoint will be evaluated by a medical committee composed by investigators not involved in the patients enrollment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Amiens University Hospital

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath